United States

Showing 1-10 of 353 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Phenotyping RElatives of persons with Diabetes with CGM and Tests of beta-cell function and health (PREDICT): an integrated longitudinal assessment of deep metabolic phenotyping and CGM metrics in youth at risk for T1D	Yale University	Alfonso Galderisi	Cures	01-February-2023 to 30-September-2026	$747.380,88
Genetic dissection of GLP1R signaling in type 1 diabetes outcomes	Yale University	David Alagpulinsa	Improving Lives	01-April-2026 to 31-March-2027	$180.829,34
Genetic variation in RPS26 modulates beta-cell vitality and immunogenicity in type 1 diabetes	Yale University	David Alagpulinsa	Cures	01-April-2026 to 31-March-2027	$199.959,68
Harnessing hematopoietic function in acute lymphoblastic leukemia to treat type 1 diabetes	Yale University	David Alagpulinsa	Cures	01-March-2025 to 28-February-2030	$991.634,17
Home-based oral glucose tolerance test for type 1 diabetes screening	Yale University	Jennifer Sherr	Cures	01-April-2025 to 31-March-2027	$347.849,00
Engineering inflammation resistant beta cells	Yale University	Kevan Herold	Cures	01-September-2023 to 31-August-2026	$499.999,37
Understanding Role of B cells in the pathogenesis of Type 1 Diabetes and Multiple Sclerosis	Yale University	Yoshiaki Yasumizu	Cures	01-September-2025 to 31-August-2026	$149.191,66
Localized immunomodulation for long term survival of beta islets in nonhuman primates	William Marsh Rice University	Omid Veiseh	Cures	01-May-2026 to 30-April-2028	$2.013.056,40
Spatial and temporal regulation of proangiogenic factors to support islet cell transplantation	William Marsh Rice University	Omid Veiseh	Cures	01-January-2025 to 31-December-2027	$900.000,00
Intrinsic Tolerance in GINS: Dissecting the HVEM/BTLA Axis Driving Hypoimmunogenicity	Weill Medical College of Cornell University	Anna Ada Dattoli	Cures	01-April-2026 to 31-March-2027	$199.999,32